GlobalData, the industry analysis specialist, has released its new report, Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Acute Pain Therapeutics market. The report identifies the key trends shaping and driving the global Acute Pain Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Acute Pain Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Acute Pain Therapeutics market. Its scope includes -

• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Acute Pain Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. 
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
• Analysis of the current and future competition in the seven key countries Acute Pain Therapeutics market. 
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. 
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Acute Pain Therapeutics market.
• Analysis of key recent licensing and partnership agreements in Acute Pain Therapeutics market 

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. 
• Develop business strategies by understanding the trends shaping and driving the global Acute Pain Therapeutics market. 
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Acute Pain Therapeutics market in future. 
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. 
• Whats the next big thing in the global Acute Pain Therapeutics market landscape? Identify, understand and capitalize.

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6

List of Tables

List of Figures

Figure 1: Classification of Pain 7
Figure 2: Key Opinion Leaders Insights, Incidence of Acute Pain in the US and the UK 11
Figure 3: Nociceptive Pain Pathway 12
Figure 4: Pain Pathway and Interventions that Modulate Pain Activity at Each Point 13
Figure 5: Pain Measurement Scale - NRS 14
Figure 6: Pain Measurement Scale - VAS 15
Figure 7: Pain Measurement Scale - FRS 15
Figure 8: KOL Insights, Treatment of Acute Pain in the US and the UK 18
Figure 9: Acute Pain Patient Referral Pathway 19
Figure 10: KOL Insights, Referral Pathway for Acute Pain in the US and the UK 19
Figure 11: Acute Pain Therapeutics Market, Global, Revenue ($m), 2006-2011 22
Figure 12: Acute Pain Therapeutics Market, Global, Forecast ($m), 2011-2019 23
Figure 13: Acute Pain Therapeutics Market, The US, Revenue ($m), 2006-2011 24
Figure 14: Acute Pain Therapeutics Market, The US, Forecast ($m), 2011-2019 25
Figure 15: Acute Pain Therapeutics Market, France, Revenue ($m), 2006-2011 26
Figure 16: Acute Pain Therapeutics Market, France, Forecast ($m), 2011-2019 27
Figure 17: Acute Pain Therapeutics Market, Germany, Revenue ($m), 2006-2011 28
Figure 18: Acute Pain Therapeutics Market, Germany, Forecast ($m), 2011-2019 29
Figure 19: Acute Pain Therapeutics Market, Italy, Revenue ($m), 2006-2011 30
Figure 20: Acute Pain Therapeutics Market, Italy, Forecast ($m), 2011-2019 31
Figure 21: Acute Pain Therapeutics Market, Spain, Revenue ($m), 2006-2011 32
Figure 22: Acute Pain Therapeutics Market, Spain, Forecast ($m), 2011-2019 33
Figure 23: Acute Pain Therapeutics Market, The UK, Revenue ($m), 2006-2011 34
Figure 24: Acute Pain Therapeutics Market, The UK, Forecast ($m), 2011-2019 35
Figure 25: Acute Pain Therapeutics Market, Japan, Revenue ($m), 2006-2011 36
Figure 26: Acute Pain Therapeutics Market, Japan, Forecast ($m), 2011-2019 37
Figure 27: Opportunity and Unmet Need in the Acute Pain Therapeutics Market, 2011 39
Figure 28: Acute Pain Therapeutics, Strategic Competitor Assessment, 2012 42
Figure 29: Acute Pain Therapeutics, Pipeline by Phase of Development, 2012 58
Figure 30: Acute Pain Therapeutics, Technology Trends Analytics Framework, 2012 61
Figure 31: Acute Pain Therapeutics, Technology Trends Analytics Framework - Description, 2012 62
Figure 32: Acute Pain Therapeutics, Pipeline by Mechanism of Action, 2012 63
Figure 33: Acute Pain Therapeutics Market, Clinical Trials by Country, 2012 68
Figure 34: Acute Pain Therapeutics, Clinical Trials by Phase, 2012 69
Figure 35: Acute Pain Therapeutics, Clinical Trials by Status, 2012 70
Figure 36: Acute Pain Therapeutics Market, Overall Sponsors, 2012 71
Figure 37: Acute Pain Therapeutics, Prominent Sponsors, 2012 72
Figure 38: Acute Pain Therapeutics, Top Companies Participating in Acute Pain Therapeutics Clinical Trials, 2012 73
Figure 39: Acute Pain Therapeutics Market, Drivers and Restraints, 2012 74
Figure 40: Implications for Future Market Competition in the Acute Pain Market, 2012 74
Figure 41: Acute Pain Therapeutics Market, Pipeline by Company, 2012 76
Figure 42: GlobalData Market Size Estimation 84
Figure 43: GlobalData Market Forecasting Model 86